Peer-reviewedLicence not statedJAMA Dermatology
Estrogen Use and Porphyria Cutanea Tarda
- 1Department of Clinical Pharmacology, Copenhagen University Hospital, Bispebjerg and Frederiksberg, Copenhagen, Denmark
- 2Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark
- 3Department of Dermatology, Copenhagen University Hospital, Bispebjerg and Frederiksberg, Copenhagen, Denmark
Related
- Differential chromatin enrichment of histone H3K27me3 underlies variable cell responses to estrogen and endocrine treatment
- 1170 Spatial transcriptomics identifies immune heterogeneity in estrogen receptor positive postpartum breast cancer
- Metabolic rewiring at the obesity-estrogen-polyamine axis in endometrial cancer: emerging mechanisms and translational opportunities.
- WTAP Transcriptional Suppression by KLF9 Drives Osteoclastogenesis via M6A‐Mediated Regulation of CSF1R Signaling in Estrogen‐Deficient Osteoporosis
- Integrated Transcriptomic and Biochemical Analyses Reveal Coordinated Suppression of ER-Associated Survival Signaling and Activation of ROS-Mediated Stress Responses by Oxidized Graphene Quantum Dots in Estrogen Receptor-Positive Breast Cancer
BibTeX
@article{erichsen2026estrogen,
title = {{Estrogen Use and Porphyria Cutanea Tarda}},
author = {Philip Ahle Erichsen and Ida M. Heerfordt and Mette Mogensen and Rasmus Huan Olsen and Henrik Horwitz},
journal = {JAMA Dermatology},
year = {2026},
month = oct,
doi = {10.1001/jamadermatol.2026.4329},
url = {https://doi.org/10.1001/jamadermatol.2026.4329},
}
RIS
TY - JOUR
TI - Estrogen Use and Porphyria Cutanea Tarda
AU - Philip Ahle Erichsen
AU - Ida M. Heerfordt
AU - Mette Mogensen
AU - Rasmus Huan Olsen
AU - Henrik Horwitz
PY - 2026
DA - 2026/10/28
JO - JAMA Dermatology
DO - 10.1001/jamadermatol.2026.4329
UR - https://doi.org/10.1001/jamadermatol.2026.4329
SN - 2168-6068
SN - 2168-6084
ER -